White House Pulls Dr. Heidi Overton as Nominee for FDA Commissioner

The Trump Administration has withdrawn its nomination of Heidi Overton, M.D. for the next Commissioner of the U.S. Food and Drug Administration (FDA), revealed Axios.
The White House made its decision after it became clear that Dr. Overton would not have enough support even among Republican senators to advance her nomination.
Multiple sources have reported that Dr. Overton’s lack of support stemmed from concerns unrelated to food safety, including her role in the Trump Administration’s controversial vaccine schedule changes. Her stance on reproductive rights issues also garnered disagreement for different reasons from members in both parties.
As a board-certified public health and general medicine practitioner, Dr. Overton does not have a background in food policy or food safety, which was underlined by her performance in a Senate confirmation hearing in September.
Dr. Overton was an ally of President Trump, having previously held roles in the first Administration and at the Trump-aligned think tank the America First Policy Institute.
With limited time before the recently elected, Democratic-majority Congress is sworn in, it is likely that confirming a permanent FDA Commissioner could fall to Senate Democrats.
Semafor first reported that Republicans are considering Senator Roger Marshall, M.D. (R-KS), who lost his seat in the recent election to Democrat Adam Hamilton, as the nominee to replace Dr. Overton.
Looking for quick answers on food safety topics?
Try Ask FSM, our new smart AI search tool.
Ask FSM →
“[Senator] Marshall is viewed as an alternative if [Dr. Overton] can’t make it through,” a Trump Administration official told Semafor. “Senators have an easier time getting confirmed, traditionally.” Still, the source acknowledged, “At this point, it’s hard to get anyone approved.”
The next FDA Commissioner will take over from Kyle Diamantas, J.D., the agency’s Interim Commissioner and previous head of the Human Foods Program, who temporarily stepped into the position after the last Commissioner, Marty Makary, M.D., parted ways with FDA in May after just one year in office.









